Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Sept 2023 for Catalyst Biosciences, INC.. Read the official filing
Filing timeline
BuySaleSeline E. Miller
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +92.9%Entry 85.00 · Close at T+365 164.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Seline E. Miller: trading record in brief
Seline E. Miller is a declared insider of Gyre Therapeutics, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 9 February 2022 to 31 August 2023.
The open-market record is one-sided, with 2 purchases worth €2,805 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 1 September 2023, reports a transaction in Gyre Therapeutics, Inc. The most recent open-market purchase was published on 10 August 2022, 1,530 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Seline E. Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6.5 sharesSeries Y Preferred StockSEC:0001140361-23-042369:0
3,250 shares@ US$0.4753.3% of flowCommon StockSEC:0001209191-22-045254:0
Canonical exit: 7 Nov 2022 (T+90)
3,250 shares@ US$0.4646.7% of flowCommon StockSEC:0001209191-22-010403:0
Canonical exit: 10 May 2022 (T+90)
3 of 2 declarations
